18 related articles for article (PubMed ID: 12916057)
1. Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptor.
Kennedy JP; Bridges TM; Gentry PR; Brogan JT; Kane AS; Jones CK; Brady AE; Shirey JK; Conn PJ; Lindsley CW
ChemMedChem; 2009 Oct; 4(10):1600-7. PubMed ID: 19705385
[No Abstract] [Full Text] [Related]
2. Heteroatom analogues of hydrocodone: synthesis and biological activity.
Giacometti RD; Duchek J; Werner L; Husni AS; McCurdy CR; Cutler SJ; Cox DP; Hudlicky T
J Org Chem; 2013 Apr; 78(7):2914-25. PubMed ID: 23397939
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 5-(4-alkoxy-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydropyrimidi ne oxalate salts and their evaluation as muscarinic receptor agonists.
Park JG; Lee MJ; Kong JY; Jung MH
Arch Pharm (Weinheim); 2000 May; 333(5):113-7. PubMed ID: 10863794
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and muscarinic activity of 1,2,3,4-tetrahydropyrimidine derivatives.
Jung MH; Park JG; Yang KJ; Lee MJ
Arch Pharm (Weinheim); 2001 Mar; 334(3):79-85. PubMed ID: 11315338
[TBL] [Abstract][Full Text] [Related]
6. 1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives.
Jeppesen L; Olesen PH; Hansen L; Sheardown MJ; Thomsen C; Rasmussen T; Jensen AF; Christensen MS; Rimvall K; Ward JS; Whitesitt C; Calligaro DO; Bymaster FP; Delapp NW; Felder CC; Shannon HE; Sauerberg P
J Med Chem; 1999 Jun; 42(11):1999-2006. PubMed ID: 10354408
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.
Tejada FR; Nagy PI; Xu M; Wu C; Katz T; Dorsey J; Rieman M; Lawlor E; Warrier M; Messer WS
J Med Chem; 2006 Dec; 49(25):7518-31. PubMed ID: 17149881
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 5-(4-alkylsulfanyl-[1, 2, 5]thiadiazol-3-yl)-3-methyl-1, 2, 3, 4-tetrahydropyrimidine oxalate salts and their evaluation as muscarinic receptor agonists.
Jung MH; Park JG; Park WK
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):230-5. PubMed ID: 12916057
[TBL] [Abstract][Full Text] [Related]
9. Pentatomic cyclic agonists and muscarinic receptors: a 20 years review.
Angeli P
Farmaco; 1995 Sep; 50(9):565-77. PubMed ID: 7495467
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
